Logo image of TNFA

TNF PHARMACEUTICALS INC (TNFA) Stock Price, Quote, News and Overview

NASDAQ:TNFA - Nasdaq - US62856X2018 - Common Stock - Currency: USD

0.1294  +0.04 (+47.89%)

After market: 0.1147 -0.01 (-11.36%)

TNFA Quote, Performance and Key Statistics

TNF PHARMACEUTICALS INC

NASDAQ:TNFA (7/21/2025, 8:00:01 PM)

After market: 0.1147 -0.01 (-11.36%)

0.1294

+0.04 (+47.89%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High2.16
52 Week Low0.08
Market Cap1.83M
Shares14.18M
Float14.17M
Yearly Dividend0.5
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-18 2025-08-18
IPO07-24 2008-07-24


TNFA short term performance overview.The bars show the price performance of TNFA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40 -60 -80

TNFA long term performance overview.The bars show the price performance of TNFA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of TNFA is 0.1294 USD. In the past month the price decreased by -7.24%. In the past year, price decreased by -93.26%.

TNF PHARMACEUTICALS INC / TNFA Daily stock chart

TNFA Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 55.39 722.35B
JNJ JOHNSON & JOHNSON 16.44 395.46B
NVO NOVO-NORDISK A/S-SPONS ADR 17.69 288.46B
NVS NOVARTIS AG-SPONSORED ADR 12.9 220.96B
AZN ASTRAZENECA PLC-SPONS ADR 15.8 213.06B
MRK MERCK & CO. INC. 10.18 199.15B
PFE PFIZER INC 7.56 137.93B
SNY SANOFI-ADR 10.56 116.71B
BMY BRISTOL-MYERS SQUIBB CO 6.36 95.02B
GSK GSK PLC-SPON ADR 8.15 73.23B
ZTS ZOETIS INC 24.48 65.61B
TAK TAKEDA PHARMACEUTIC-SP ADR 62.78 45.11B

About TNFA

Company Profile

TNFA logo image TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The firm is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. Isomyosamine works by regulating the release of numerous pro-inflammatory cytokines. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the CBD market, which includes both Food and Drug Administration (FDA) approved drugs and CBD products not regulated as drugs.

Company Info

TNF PHARMACEUTICALS INC

1185 Avenue Of The Americas, Suite 249

New York City NEW YORK US

Employees: 2

TNFA Company Website

TNFA Investor Relations

Phone: 18568488698

TNF PHARMACEUTICALS INC / TNFA FAQ

What is the stock price of TNF PHARMACEUTICALS INC today?

The current stock price of TNFA is 0.1294 USD. The price increased by 47.89% in the last trading session.


What is the ticker symbol for TNF PHARMACEUTICALS INC stock?

The exchange symbol of TNF PHARMACEUTICALS INC is TNFA and it is listed on the Nasdaq exchange.


On which exchange is TNFA stock listed?

TNFA stock is listed on the Nasdaq exchange.


What is TNF PHARMACEUTICALS INC worth?

TNF PHARMACEUTICALS INC (TNFA) has a market capitalization of 1.83M USD. This makes TNFA a Nano Cap stock.


How many employees does TNF PHARMACEUTICALS INC have?

TNF PHARMACEUTICALS INC (TNFA) currently has 2 employees.


What are the support and resistance levels for TNF PHARMACEUTICALS INC (TNFA) stock?

TNF PHARMACEUTICALS INC (TNFA) has a support level at 0.12. Check the full technical report for a detailed analysis of TNFA support and resistance levels.


Should I buy TNF PHARMACEUTICALS INC (TNFA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TNF PHARMACEUTICALS INC (TNFA) stock pay dividends?

TNFA does not pay a dividend.


When does TNF PHARMACEUTICALS INC (TNFA) report earnings?

TNF PHARMACEUTICALS INC (TNFA) will report earnings on 2025-08-18.


What is the Short Interest ratio of TNF PHARMACEUTICALS INC (TNFA) stock?

The outstanding short interest for TNF PHARMACEUTICALS INC (TNFA) is 27.62% of its float. Check the ownership tab for more information on the TNFA short interest.


TNFA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TNFA Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

TNFA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to TNFA. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners1.44%
Ins Owners0.07%
Short Float %27.62%
Short Ratio0.68
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A